LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,303,699 | $1,267,175 | $1,097,310 | $925,334 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Cost of Goods Sold | $322,264 | $271,538 | $223,382 | $177,800 |
| Gross Profit | $981,435 | $995,637 | $873,928 | $747,534 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| R&D Expenses | $302,915 | $297,921 | $208,481 | $145,886 |
| G&A Expenses | $164,583 | $149,251 | $102,478 | $97,022 |
| SG&A Expenses | $504,202 | $414,590 | $347,700 | $291,175 |
| Sales & Mktg Exp. | $339,619 | $265,339 | $245,222 | $194,153 |
| Other Operating Expenses | -$12,018 | -$100,152 | -$58,187 | -$16,197 |
| Operating Expenses | $795,099 | $612,359 | $497,994 | $420,864 |
| Operating Income | $186,336 | $383,278 | $375,934 | $328,739 |
| % Margin | 14.3% | 30.2% | 34.3% | 35.5% |
| Other Income/Exp. Net | $12,659 | -$207,697 | $2,112 | $4,189 |
| Pre-Tax Income | $198,995 | $175,581 | $378,046 | $332,928 |
| Tax Expense | $30,504 | $68,091 | $59,307 | $49,571 |
| Net Income | $222,388 | $263,242 | $325,337 | $292,472 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS | 0.051 | 0.059 | 0.077 | 0.068 |
| % Growth | -13.6% | -23.4% | 13.2% | – |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| Weighted Avg Shares Out | 4,379,345 | 4,461,729 | 4,233,222 | 4,562,892 |
| Weighted Avg Shares Out Dil | 4,394,487 | 4,446,121 | 4,405,420 | 4,562,892 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18,569 | $12,783 | $16,649 | $14,381 |
| Interest Expense | $1,890 | $722 | $632 | $2,609 |
| Depreciation & Amortization | $87,996 | $77,159 | $67,106 | $62,051 |
| EBITDA | $288,881 | $253,462 | $445,784 | $397,588 |
| % Margin | 22.2% | 20% | 40.6% | 43% |